• 1
    Bauer W, Aub JC, Albright F 1929 Studies of calcium phosphorus metabolism. V. A study of the bone trabeculae as a readily available reserve supply of calcium. J Exp Med 49:145162.
  • 2
    Selye H 1932 On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16:547.
  • 3
    Reeve J, Tregear GW, Parsons JA 1976 Preliminary trial of low doses of human parathyroid 1-34 peptide in treatment of osteoporosis. Clin Endocrinol (Oxf) 21:469.
  • 4
    Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, Edouard C, Lenerman L, Neer RM, Renier JC, Slovik D, Vismans FJFE, Potts JT 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. BMJ 280:13401344.
  • 5
    Slovik DM, Rosenthal DI, Doppelt S, Potts JTJ, Daly MA, Campbell JA, Neer RM 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-84) and 1,25 dihydroxyvitamin D. J Bone Miner Res 1:377.
  • 6
    Finkelstein JJS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM 1994 Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618.
  • 7
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomized controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550555.
  • 8
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D 1997 A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in post-menopausal women with osteoporosis. J Clin Endocrinol Metab 82:620.
  • 9
    Roe EB, Sanchez SD, Del Puerto A, Bachetti P, Cann CE, Arnaud CD 1999 Parathyroid hormone 1-34 (hPTH 1-34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis—results from a placebo-controlled randomized trial. J Bone Miner Res 14:S1;S137.(abstract)
  • 10
    Lane NE, Sanchez S, Modin GW, Genant HK, Ini E, Arnaud CD 1998 Parathyroid hormone can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:16271633.
  • 11
    Cosman F, Nieves J, Formica C, Woelfert L, Shen V, Lindsay R 2000 Parathyroid hormone in combination with estrogen dramatically reduces vertebral fracture risk. Osteopor Int 11(Suppl 2):S176.(abstract)
  • 12
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich G, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:14341441.
  • 13
    Bradbeer JN, Arlot ME, Meunier PJ, Reeve J 1992 Treatment of osteoporosis with parathyroid peptide (h-PTH 1-34) and oestrogen: Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol (Oxf) 37:282289.
  • 14
    Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH 2000 Histomorphometric evidence of increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis Bone 27:311318.
  • 15
    Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP 1997 Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 82:27992805.
  • 16
    Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP 2000 Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:30693076.
  • 17
    Dempster DW, Shane ES 1995 Bone quantification and dynamics of bone turnover by histomorphometric analysis. In: BeckerKL (ed.) Principles and Practice of Endocrinology and Metabolism, 2nd ed. JB Lippincott Co., Philadelphia, PA, USA, pp. 491498.
  • 18
    Parisien M, Silverberg SJ, Shane E, De La Cruz L, Lindsay R, Bilezikian J, Dempster DW 1990 The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930938.
  • 19
    Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP, Dempster DW 1995 Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women. J Bone Miner Res 10:13931399.
  • 20
    Parisien MP, Cosman F, Morgan D, Schnitzer M, Liang X, Nieves J, Forese L, Luckey M, Meier D, Shen V, Lindsay R, Dempster DW 1997 Histomorphometric assessment of bone mass, structure, and remodeling: A comparison between healthy black and white premenopausal women. J Bone Miner Res 12:948957.
  • 21
    Dempster DW, Parisien M, Silverberg SJ, Liang X-G, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP 1999 On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:15621566.
  • 22
    Parfitt AM, Drezner HK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595610.
  • 23
    Courpron P, Meunier PJ, Bressot C, Giroux JM 1976 Amount of bone in iliac crest biopsy: Significance of the trabecular bone volume. Its values in normal and in pathological conditions. In: Meunier PJ (ed.) Proceedings of Bone Histomorphometry. Second International Workshop, Lyon. Societe de la Nouvelle Imprimerie Fournie, Toulouse, pp. 3953.
  • 24
    Hildebrand T, Laib A, Müller R, Dequeker J, Rüegsegger P 1999 Direct three-dimensional morphometric analysis of human cancellous bone: Microstructural data from spine, femur, iliac crest and calcaneous. J Bone Miner Res 14:11671174.
  • 25
    Lorensen WE, Cline HE 1987 Marching cubes: A high resolution 3D surface construction algorithm. Comput Graph 21:163169.
  • 26
    Guilak F 1994 Volume and surface area of viable chondrocytes in situ using geometric modelling of serial confocal sections. J Microsc 173:245256.
  • 27
    Hildebrand T, Rüegsegger P 1997 A new method for the model independent assessment of thickness in three-dimensional images. J Microsc 185:6775.
  • 28
    Odgaard A, Gundersen HJ 1993 Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 14:173182.
  • 29
    Odgaard A 1997 Three dimensional methods for quantification of cancellous bone architecture. Bone 20:315328.
  • 30
    Horwitz M, Stewart A, Greenspan SL 2000 Editorial: Sequential parathyroid hormone/alendronate therapy for osteoporosis—robbing Peter to pay Paul? J Clin Endocrinol Metab 85:21272128.
  • 31
    Vesterby A, Mosekilde L, Gundersen HJG, Melsen F, Mosekilde L, Holme K, Sorenesen S 1991 Biologically meaningful determinants of the in vitro strength of lumbar vertebrae. Bone 12:219224.
  • 32
    Ritzel H, Amling M, Posl M, Hahn M, Delling G 1997 The thickness of human vertebral cortical bone and its changes in aging and osteoporosis: A histomorphometric analysis of the complete spinal column from thirty-seven autopsy specimens. J Bone Miner Res 12:8995.
  • 33
    Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P 2000 Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Miner Res 15:13681375.
  • 34
    Oxlund H, Ejersted C, Andreassen T, Torring O, Nilsson MHL 1993 Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394399.
  • 35
    Wronski TJ, Yen C-F 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:5158.
  • 36
    Ejersted C, Oxlund H, Eriksen EF, Andreassen TT 1998 Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats. Bone 23:4352.
  • 37
    Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 1999 Anabolic effects of human biosynthetic parathyroid fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536545.
  • 38
    Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF 1996 Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)2D3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600613.
  • 39
    Cain RL, Zeng QQ, Rowley ER, Cole HW, Bryant H, Sato M, Ma YL 2000 PTH augments similar cortical bone in rats regardless of ovarian status—a histomorphometric analysis J Bone Miner Res 15:S1;S441.(abstract)
  • 40
    Mohan S, Kutilek S, Zhang C, Shen HG, Kodama Y, Srivistava AK, Wergedal JE, Beamer WG, Baylink DJ 2000 Comparison of bone formation responses to parathyroid hormone (1-34), (1-31), and (2-34) in mice. Bone 27:471478.
  • 41
    Cann CE, Roe EB, Sanchez SD, Arnaud CD 1999 PTH effects in the femur: Envelope-specific responses by 3D-QCT in postmenopausal women. J Bone Miner Res 14:S1;S137.(abstract)
  • 42
    Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M 1997 Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501506.
  • 43
    Kurland ES, Cosman F, Rosen CJ, Lindsay R, Bilezikian JP 2000 Parathyroid hormone (PTH 1-34) as a treatment for idiopathic osteoporosis in men: Changes in bone mineral density, bone markers, and optimal duration of therapy. J Bone Miner Res 15:S1;S230.(abstract)
  • 44
    Cosman F, Lindsay R 1998 Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475480.
  • 45
    Kabel J, Odgaard A, Van Rietbergen B, Huiskes R 1999 Connectivity and the elastic properties of cancellous bone. Bone 24:115120.
  • 46
    Borah B, Dufresne TE, Cockman MD, Gross GL, Sod EW, Myers WR, Combs KS, Higgins RE, Pierce SA, Stevens ML 2000 Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res 15:17861797.
  • 47
    Kinney JH, Ladd AJC 1998 The relationship between three-dimensional connectivity and the elastic properties of trabecular bone. J Bone Miner Res 13:839845.
  • 48
    Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:24792487.
  • 49
    Sato M, Zeng GQ, Turner CH 1997 Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:43304337.
  • 50
    Parisien MV, Mellish RWE, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW 1992 Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis. J Bone Miner Res 7:913919.
  • 51
    Vogel M, Hahn M, Delling G 1995 Trabecular structure in patients with primary hyperparathyroidism. Virchows Arch 426:127134.
  • 52
    Boyce RW, Wronski TJ, Ebert DC, Stevens ML, Paddock CL, Youngs TA, Gundersen HJG 1995 Direct stereological estimation of three-dimensional connectivity in rat vertebrae: Effects of estrogen, etidronate and risedronate following ovariectomy. Bone 16:209213.
  • 53
    Jerome CP, Burr DB, Van Bibber T, Brommage R 2001 Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150159.
  • 54
    Parisien MV, McMahon D, Pushparaj N, Dempster DW 1988 Trabecular architecture in iliac crest bone biopsies: Intra-individual variability in structural parameters and changes with age. Bone 9:289295.
  • 55
    Cosman F, Schnitzer MB, McCann PD, Parisien MV, Dempster DW, Lindsay R 1992 Relationships between quantitative histological measurements and non-invasive assessments of bone mass. Bone 13:237242.